Illumina Inc (ILMN)

$116.81 +2.37 (2.07%)
Market Cap 17.49B
Revenue (ttm) 4.34B
Net Income (ttm) 850.00M
EPS (ttm) N/A
PE Ratio 24.00
Forward PE 22.66
Profit Margin 19.57%
Debt to Equity Ratio 0.55
Volume 1,902,900
Avg Vol 1,958,394
Day's Range N/A - N/A
Shares Out 152.80M
Stochastic %K 14%
Beta 1.45
Analysts Sell
Price Target $133.74

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4545
Address:
5200 Illumina Way, San Diego, United States
ZacksResearch
ZacksResearch Feb. 12 at 4:20 PM
$ILMN beats Q4 estimates but shares tumble 10.4% — what's spooking investors? 🤔 Despite a 7.4% EPS beat and 5.4% year-over-year revenue growth in Q4, concerns over gross margin contraction are weighing on the stock. 📉 Full breakdown here 👉 https://www.zacks.com/stock/news/2861538/illumina-q4-earnings-revenues-top-estimates-stock-dips?cid=sm-stocktwits-2-2861538-body-33313&ADID=SYND_STOCKTWITS_TWEET_2_2861538_BODY_33313
0 · Reply
ZacksResearch
ZacksResearch Feb. 12 at 3:20 PM
$ILMN crushed Q4… so why did the stock drop 10%? 🤔 The company topped Q4 EPS and revenue estimates and delivered a 42% profit jump, but margin concerns overshadowed the strong print — even with a 2026 growth outlook on the table. ⚠️ Is this a short-term overreaction or a real red flag? Full breakdown here 👉 https://www.zacks.com/stock/news/2861538/illumina-q4-earnings-revenues-top-estimates-stock-dips?cid=sm-stocktwits-2-2861538-teaser-33312&ADID=SYND_STOCKTWITS_TWEET_2_2861538_TEASER_33312
0 · Reply
kb60521
kb60521 Feb. 9 at 9:52 PM
$ILMN Any longtimer here? what are your thoughts and expectations? can you please share...
1 · Reply
kb60521
kb60521 Feb. 9 at 8:49 PM
$ILMN Morning I should have invested in HIMS when I had a choice.....
0 · Reply
medguy
medguy Feb. 9 at 8:17 PM
I'm in $ILMN
0 · Reply
Farorm
Farorm Feb. 9 at 5:28 PM
$ILMN 10 red days in a row is what’s puzzling me.
0 · Reply
kb60521
kb60521 Feb. 9 at 5:16 PM
$ILMN Anyone else seeing 130 EoW???
0 · Reply
SGCoin2
SGCoin2 Feb. 6 at 5:14 PM
$ILMN 🚀⏰ $ILMN
0 · Reply
erpy
erpy Feb. 6 at 4:08 PM
$ILMN For the illiterate that cant read. They destroyed eps estimates. They beat revenues estimates. They gave good guidance. Dont fall for this bearish bullshit share price is showing. Guaranteed recurring revenues, great merger or buyout candidate. LOAD MY BOAT.... just my humble opinion.
1 · Reply
Bazzzigar
Bazzzigar Feb. 6 at 4:01 PM
$ILMN geopolitical risk
0 · Reply
Latest News on ILMN
Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript

Feb 5, 2026, 8:14 PM EST - 8 days ago

Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

Feb 5, 2026, 4:06 PM EST - 8 days ago

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally

Feb 3, 2026, 9:15 AM EST - 11 days ago

Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally

Illumina completes acquisition of SomaLogic

Jan 30, 2026, 9:05 AM EST - 15 days ago

Illumina completes acquisition of SomaLogic

Illumina Gets Medicare Boost for Cancer Test, Shares Climb

Jan 20, 2026, 1:19 PM EST - 24 days ago

Illumina Gets Medicare Boost for Cancer Test, Shares Climb

Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology

Jan 20, 2026, 9:15 AM EST - 25 days ago

Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology

GRAIL Inc. - Illumina's Divested Holy Grail

Jan 20, 2026, 8:34 AM EST - 25 days ago

GRAIL Inc. - Illumina's Divested Holy Grail

GRAL

Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 2:25 PM EST - 4 weeks ago

Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Illumina unveils dataset to speed up AI-powered drug discovery

Jan 13, 2026, 9:18 AM EST - 4 weeks ago

Illumina unveils dataset to speed up AI-powered drug discovery

Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery

Jan 13, 2026, 9:15 AM EST - 4 weeks ago

Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Jan 13, 2026, 9:00 AM EST - 4 weeks ago

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Jan 12, 2026, 4:07 PM EST - 4 weeks ago

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Illumina Appoints Dr. Eric Green as Chief Medical Officer

Jan 8, 2026, 4:30 PM EST - 5 weeks ago

Illumina Appoints Dr. Eric Green as Chief Medical Officer

Illumina and PREMIA partner to expand clinical access to CGP in Asia

Jan 8, 2026, 8:07 AM EST - 5 weeks ago

Illumina and PREMIA partner to expand clinical access to CGP in Asia

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis

Jan 6, 2026, 9:15 AM EST - 5 weeks ago

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis

Illumina To Webcast Upcoming Investor Conference

Dec 16, 2025, 4:05 PM EST - 2 months ago

Illumina To Webcast Upcoming Investor Conference

Santa Rally Looms: These 5 Stocks Often Deliver Gifts To Investors

Dec 16, 2025, 2:29 PM EST - 2 months ago

Santa Rally Looms: These 5 Stocks Often Deliver Gifts To Investors

CAT FCX GS JPM

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Dec 11, 2025, 9:15 AM EST - 2 months ago

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Nov 19, 2025, 2:23 PM EST - 3 months ago

Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

Nov 12, 2025, 12:00 PM EST - 3 months ago

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation

Nov 10, 2025, 1:16 PM EST - 3 months ago

Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation

CSCO FTAI MS

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

Nov 10, 2025, 12:15 PM EST - 3 months ago

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

LAB

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

Nov 5, 2025, 5:16 PM EST - 3 months ago

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars

Oct 31, 2025, 12:01 PM EDT - 3 months ago

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars

Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 10:26 PM EDT - 3 months ago

Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Oct 30, 2025, 4:05 PM EDT - 3 months ago

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Illumina: Innovation Outweighs Short-Term Risks - A Long-Term Buy Ahead Of Q3 Earnings

Oct 21, 2025, 2:16 PM EDT - 4 months ago

Illumina: Innovation Outweighs Short-Term Risks - A Long-Term Buy Ahead Of Q3 Earnings

Final Trades: Illumina, Columbia Banking, Alibaba and JPMorgan Chase

Oct 20, 2025, 4:21 PM EDT - 4 months ago

Final Trades: Illumina, Columbia Banking, Alibaba and JPMorgan Chase

BABA COLB JPM

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

Oct 15, 2025, 9:15 AM EDT - 4 months ago

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 4 months ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

WGS

Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

Oct 14, 2025, 4:05 PM EDT - 4 months ago

Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

Illumina launches new business to accelerate technology and data-driven discovery

Oct 1, 2025, 9:05 AM EDT - 4 months ago

Illumina launches new business to accelerate technology and data-driven discovery

ILMN Stock vs. IQV Stock

Sep 26, 2025, 9:40 AM EDT - 5 months ago

ILMN Stock vs. IQV Stock

IQV

Illumina advances personalized cancer care with new pharma development partnerships

Sep 23, 2025, 9:15 AM EDT - 5 months ago

Illumina advances personalized cancer care with new pharma development partnerships

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

Sep 18, 2025, 9:15 AM EDT - 5 months ago

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

ALNY

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

Sep 3, 2025, 9:15 AM EDT - 5 months ago

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

LAB

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 6 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL IONS MRNA RGEN

Illumina: The Stock Is Still Undervalued

Aug 4, 2025, 4:23 AM EDT - 6 months ago

Illumina: The Stock Is Still Undervalued

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results

Aug 1, 2025, 12:02 PM EDT - 7 months ago

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 1:25 AM EDT - 7 months ago

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025

Jul 31, 2025, 4:05 PM EDT - 7 months ago

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025

Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling

Jul 30, 2025, 9:15 AM EDT - 7 months ago

Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling

Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Jul 17, 2025, 7:45 AM EDT - 7 months ago

Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds

Jul 12, 2025, 3:46 AM EDT - 7 months ago

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Jul 10, 2025, 4:05 PM EDT - 7 months ago

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

Jul 10, 2025, 9:15 AM EDT - 7 months ago

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

Jun 23, 2025, 7:13 AM EDT - 8 months ago

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

LAB

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

Jun 18, 2025, 9:00 AM EDT - 8 months ago

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Jun 10, 2025, 4:01 PM EDT - 8 months ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

May 29, 2025, 2:01 PM EDT - 9 months ago

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

ZacksResearch
ZacksResearch Feb. 12 at 4:20 PM
$ILMN beats Q4 estimates but shares tumble 10.4% — what's spooking investors? 🤔 Despite a 7.4% EPS beat and 5.4% year-over-year revenue growth in Q4, concerns over gross margin contraction are weighing on the stock. 📉 Full breakdown here 👉 https://www.zacks.com/stock/news/2861538/illumina-q4-earnings-revenues-top-estimates-stock-dips?cid=sm-stocktwits-2-2861538-body-33313&ADID=SYND_STOCKTWITS_TWEET_2_2861538_BODY_33313
0 · Reply
ZacksResearch
ZacksResearch Feb. 12 at 3:20 PM
$ILMN crushed Q4… so why did the stock drop 10%? 🤔 The company topped Q4 EPS and revenue estimates and delivered a 42% profit jump, but margin concerns overshadowed the strong print — even with a 2026 growth outlook on the table. ⚠️ Is this a short-term overreaction or a real red flag? Full breakdown here 👉 https://www.zacks.com/stock/news/2861538/illumina-q4-earnings-revenues-top-estimates-stock-dips?cid=sm-stocktwits-2-2861538-teaser-33312&ADID=SYND_STOCKTWITS_TWEET_2_2861538_TEASER_33312
0 · Reply
kb60521
kb60521 Feb. 9 at 9:52 PM
$ILMN Any longtimer here? what are your thoughts and expectations? can you please share...
1 · Reply
kb60521
kb60521 Feb. 9 at 8:49 PM
$ILMN Morning I should have invested in HIMS when I had a choice.....
0 · Reply
medguy
medguy Feb. 9 at 8:17 PM
I'm in $ILMN
0 · Reply
Farorm
Farorm Feb. 9 at 5:28 PM
$ILMN 10 red days in a row is what’s puzzling me.
0 · Reply
kb60521
kb60521 Feb. 9 at 5:16 PM
$ILMN Anyone else seeing 130 EoW???
0 · Reply
SGCoin2
SGCoin2 Feb. 6 at 5:14 PM
$ILMN 🚀⏰ $ILMN
0 · Reply
erpy
erpy Feb. 6 at 4:08 PM
$ILMN For the illiterate that cant read. They destroyed eps estimates. They beat revenues estimates. They gave good guidance. Dont fall for this bearish bullshit share price is showing. Guaranteed recurring revenues, great merger or buyout candidate. LOAD MY BOAT.... just my humble opinion.
1 · Reply
Bazzzigar
Bazzzigar Feb. 6 at 4:01 PM
$ILMN geopolitical risk
0 · Reply
erpy
erpy Feb. 6 at 3:28 PM
$ILMN Nice results time to load!!
1 · Reply
StockAnalyticsAI
StockAnalyticsAI Feb. 6 at 2:03 PM
$ILMN Illumina (ILMN) February 2026 Earnings Analysis: Complete Financial Brea... https://youtu.be/o84AVC9wcaU?is=aUmbo-1IpFnlsEfh via @YouTube
0 · Reply
TheBench
TheBench Feb. 6 at 1:40 PM
$ILMN Not to give false hope.. But, As a long time holder of ILMN it seems after a decent/good earnings report. The stock seems tonslide after hrs or next day. Then rebounds nicely
2 · Reply
InItToWinIt100
InItToWinIt100 Feb. 6 at 4:01 AM
Post Market Gappers & Crappers $CCHH $RGTZ $MOH $SNDK $ILMN https://www.trade-ideas.com/share.php?code=HM4kTUyOKtb7eHTQuXe56Zm6WkSWn4MY
0 · Reply
Estimize
Estimize Feb. 6 at 12:12 AM
$ILMN reported 1.35 EPS and 1,159 revenue for Q4. http://www.estimize.com/intro/ilmn?chart=historical&metric_name=eps&utm_content=ILMN&utm_
0 · Reply
HarveyToronto
HarveyToronto Feb. 5 at 10:07 PM
$ILMN added. Be greedy when the market is fearful
0 · Reply
Farorm
Farorm Feb. 5 at 10:03 PM
$ILMN fu*k you market mother f*cker 🤡
0 · Reply
Farorm
Farorm Feb. 5 at 9:38 PM
$ILMN good earnings and the market just want to send it down.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 5 at 9:16 PM
$ILMN Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $2.18 up 86.32% YoY • Reported revenue of $1.16B up 4.98% YoY • Illumina expects fiscal year 2026 total company revenue of $4.5B to $4.6B, growing 4% to 6% on a reported basis, and non-GAAP diluted EPS in the range of $5.05 to $5.20.
0 · Reply
CatCapital_ai
CatCapital_ai Feb. 5 at 9:13 PM
$ILMN Earnings - Q4/2025 Revenue: $1.16B ✅ vs. $1.09B est. EPS: $1.35 ✅ vs. $1.17 est. Illumina finishes 2025 on a growth note, led by clinical markets and expanding multiomics momentum. Q4 margins were GAAP 17.4% and non-GAAP 23.7%; full-year margins were GAAP 18.6% and non-GAAP 23.1%. Guidance calls for non-GAAP operating margin in the range of 23.3%–23.5%, including a 100bp drag from the SomaLogic acquisition.
0 · Reply
DonCorleone77
DonCorleone77 Feb. 5 at 7:36 PM
$BE $RDDT $TEAM $ILMN $AFRM Some notable companies reporting after the market close, with earnings consensus estimates: - Amazon (AMZN), consensus $1.96 - Fortinet (FTNT), consensus 74c - Monolithic Power (MPWR), consensus $4.74 - Roblox (RBLX), consensus (-46) - Microchip (MCHP), consensus 43c - Bloom Energy (BE), consensus 30c - Reddit (RDDT), consensus 93c - Atlassian (TEAM), consensus $1.14 - Illumina (ILMN), consensus $1.23 - Affirm (AFRM), consensus 84c - Molina (MOH), consensus 33c - Paylocity (PCTY), consensus $1.60 - Doximity (DOCS), consensus 45c.
0 · Reply
Eddyg987
Eddyg987 Feb. 5 at 6:22 PM
$ILMN I'm not currently holding, but it's obvious this is going up we are currently experiencing a biotech revolution and they will need all the analyzers they can get their hands on. I like $TXG more, recently $ILMN stole their tech they will deal with that in court, but it will take a few years and by then $ILMN will have made their money.
0 · Reply